Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
-
Surg Obes Relat Dis · Jan 2009
Feasibility and technique of laparoscopic conversion of adjustable gastric banding to sleeve gastrectomy.
To evaluate the feasibility, safety, and short-term efficacy of the conversion of laparoscopic adjustable gastric banding (LAGB) to laparoscopic sleeve gastrectomy (LSG) because of inadequate weight loss. ⋯ The results of this study support the safety of LSG in the case of an inadequate %EWL after LAGB. However, the degree of weight loss and co-morbidity resolution is of concern.
-
Surg Obes Relat Dis · Jan 2009
Randomized Controlled Trial Comparative StudyPreinductive use of clonidine and ketamine improves recovery and reduces postoperative pain after bariatric surgery.
In obese patients, concomitant use of clonidine and ketamine might be suitable to reduce the doses and minimize the undesired side effects of anesthetic and analgesic drugs. In this study, we evaluated the perioperative effects of administration of clonidine and ketamine in morbidly obese patients undergoing weight loss surgery at a university hospital in Rome, Italy. ⋯ The preoperative administration of low doses of ketamine and clonidine at induction appears to provide early extubation and diminished postoperative analgesic requirements in morbidly obese patients undergoing open bariatric surgery.
-
Surg Obes Relat Dis · Jan 2009
Effect of laparoscopic Roux-en-Y gastric bypass surgery on hemoglobin A1c levels in diabetic patients: a matched-cohort analysis.
Elevated hemoglobin A1c (HbA1c) values are known to increase the risk of diabetic retinopathy, nephropathy, and peripheral neuropathy. The current guidelines recommend maintaining HbA1c values at <7%. We assessed the effect of laparoscopic Roux-en-Y gastric bypass surgery (LRYGB) on HbA1c values in diabetic patients compared with a conventionally treated cohort. ⋯ The patients who underwent LRYGB had a significant and sustained improvement in the HbA1c value compared with the conventionally treated obese patients with type 2 diabetes mellitus.